University of Pittsburgh Cancer Institute (UPCI)

About UPCI

Administration

Research Executive Advisory Committee

The Research Executive Advisory Committee is focused on research-related issues. Dr. Davidson serves as chair of this committee, which also includes UPCI leaders who have responsibilities for academic and research activities. The Research Executive Advisory Committee meets twice per month to discuss a broad range of research issues, including: basic, translational, and clinical research; overall strategic planning to achieve future goals; and assessment of needs and opportunities for recruitment and infrastructure development.

Nancy E. Davidson, MD Director, UPCI and UPMC CancerCenter; Associate Vice Chancellor for Cancer Research; Hillman Professor of Oncology; Distinguished Professor of Medicine and Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine
Michael Becich, MD, PhD Chair, Department of Biomedical Informatics; Professor of Pathology, Information Sciences/Telecommunications, and Clinical/Translational Sciences; Associate Director, Cancer Informatics; Associate Director, Clinical and Translational Science Institute, University of Pittsburgh School of Medicine
Dana Bovbjerg, PhD Leader, Biobehavioral Oncology Program, UPCI; Professor of Psychiatry, Psychology, and Behavioral and Community Health Sciences, and Clinical and Translational Sciences, University of Pittsburgh
Adam Brufsky, MD, PhD Associate Director, Clinical Investigation, UPCI; Associate Chief, Hematology-Oncology, UPMC; Professor of Medicine, University of Pittsburgh School of Medicine
Edward Chu, MD Deputy Director, UPCI; Chief, Division of Hematology-Oncology; Co-Leader, Cancer Therapeutics Program, UPCI; Professor of Medicine and Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine
Maryann Donovan, PhD, MPH Associate Director, Research Administration, UPCI; Assistant Professor of Pathology, University of Pittsburgh School of Medicine
Robert L. Ferris, MD, PhD, FACS Chief, Division of Head and Neck Surgery; Associate Director for Translational Research; Co-Leader, Cancer Immunology Program, UPCI; Professor of Otolaryngology, Immunology, and Radiation Oncology, University of Pittsburgh School of Medicine
Pawel Kalinski, MD, PhD Professor of Surgery and Immunology, University of Pittsburgh School of Medicine; Professor of Infectious Disease and Microbiology, University of Pittsburgh Graduate School of Public Health; Professor of Bioengineering, University of Pittsburgh Swanson School of Engineering
Linda M. McAllister-Lucas, MD, PhD Chief of Service, Hematology/Oncology, Children's Hospital of Pittsburgh of UPMC; Associate Professor of Pediatrics, University of Pittsburgh School of Medicine
Patrick Moore, MD, MPH Leader, Cancer Virology Program, UPCI; Distinguished Professor of Microbiology & Molecular Genetics and Pittsburgh Foundation Chair in Innovative Cancer Research, University of Pittsburgh School of Medicine; American Cancer Society Professor
Daniel P. Normolle, PhD Director, Biostatistics Facility, UPCI; Associate Professor of Biostatistics, University of Pittsburgh
Shivendra V. Singh, PhD Associate Director, Basic Research, UPCI; Professor of Pharmacology & Chemical Biology, and Urology, University of Pittsburgh School of Medicine
Bennett Van Houten, PhD Co-Leader, Molecular and Cellular Cancer Biology Program, UPCI; Richard M. Cyert Professor of Molecular Oncology, and Professor of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine
Jian-Min Yuan, MD, PhD Associate Director, Cancer Control and Population Sciences, UPCI; Co-Leader, Cancer Epidemiology and Prevention Program, UPCI; Professor, Department of Epidemiology, University of Pittsburgh Graduate School of Public Health